TITLE

Recombinant human parathyroid hormone

AUTHOR(S)
Reeve, Jonathan
PUB. DATE
February 2002
SOURCE
BMJ: British Medical Journal (International Edition);2/23/2002, Vol. 324 Issue 7335, p435
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Editorial. Reports that the United States Food & Drug Administration voted in favor of the recombinant parathyroid hormone for the treatment of menopausal osteoporosis. Finding that the hormone injections increase bone mass and strength; Description of how data from animal studies helped determine the model for human treatment; Effectiveness of teriparatide in treating osteoporosis.
ACCESSION #
6267969

 

Related Articles

  • bmj updates.  // BMJ: British Medical Journal (International Edition);8/12/2006, Vol. 333 Issue 7563, preceding p311 

    The article provides a summary of the article "Parathyroid hormone for the treatment of osteoporosis: a systematic review," by A. Cranney, et al. The study evaluated the use of parathyroid hormone as a treatment for osteoporosis in women. The research found that the use of parathyroid hormone...

  • Bears, bones and osteoporosis.  // Active Living;Nov2006, Vol. 15 Issue 6, p29 

    The article discusses a review by the Scientific Advisory Council of Osteoporosis Canada which concluded that treatment with parathyroid hormone could be effective for osteoporosis. Parathyroid hormone is produced by black bears after hibernation to overcome bone loss generated by several months...

  • New options in treating osteoporosis. LoBuono, Charlotte // Drug Topics;5/5/2003 Supplement, Vol. 147 Issue 9, p9S 

    Focuses on the alternative option in the treatment of osteoporosis called teriparatide, a recombinant form of human parathyroid hormone. Recommended administration; Most common adverse effects; Other therapies for osteoporosis.

  • Teriparatide (hPTH-[1-34]). Ashworth, L.E. // Formulary;Mar2002, Vol. 37 Issue 3, p129 

    Examines the efficacy of teriparatide (hPTH-[1-34]) in treating osteoporosis. Pharmacological properties of teriparatide; Increase in the total-body bone mass density; Adverse effects of the drug.

  • New Treatment Builds Bone 'Dramatically.'.  // Arthritis Today;Nov/Dec2001, Vol. 15 Issue 6, p24 

    Presents the results of a study on the use of a synthetic human parathyroid hormone fragment in treating osteoporosis. Methods used; Significance of taking parathyroid hormone to increases in spinal bone density; Benefits in treating several types of osteoporosis.

  • Parathyroid Hormone in the Treatment of Osteoporosis. Fujita, T. // BioDrugs;2001, Vol. 15 Issue 11, p721 

    Parathyroid hormone (PTH), especially intact human PTH [hPTH(1-84)] and its various fragments [hPTH(1-31), (1-34), (1-36), (1-38) and their modifications], has been used for the treatment of osteoporosis over the last 10 years. Although chronic continuous excess of PTH markedly increases bone...

  • Parathyroid Hormone as an Anabolic Skeletal Therapy. Rubin, Mishaela R.; Bilezikian, John P. // Drugs;2005, Vol. 65 Issue 17, p2481 

    The quest for effective treatment for osteoporosis merits great attention because of the widespread prevalence of this disease, which is not only associated with fragility fractures, but also with significant morbidity and mortality. The efficacy of the antiresorptive drugs in this disease is...

  • Combination Treatments Show No Increase in BMD.  // Professional Safety;Dec2003, Vol. 48 Issue 12, p61 

    Discusses studies indicating that the combination treatment of parathyroid hormone with alendronate provides no significant improvement in bone mineral density, a procedure to cure osteoporosis. Benefits of the studies for osteoporosis patients; Clinical guidance offered by the findings to...

  • Recombinant Full-Length Parathyroid Hormone (1-84). Moen, Marit D.; Scott, Lesley J // BioDrugs;2007, Vol. 21 Issue 3, p205 

    The article discusses the importance of recombinant full-length parathyroid hormone in treating osteoporosis. Osteoporosis occurs when the rate of bone resorption exceeds the rate of bone formation. The resulting loss of bone mass and strength can lead to fragility fractures. Available...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics